3 ms·

Maximizing profits until retatrutide comes out and blows the whole market open.

• blacksmith_tb 1y ago
  Still sub-cutaneous, though? I would think whatever GLP-1 agonist that's oral-route will crush all of the competition instantly?
  • phonon 1y ago
    Well, oral will be less effective (not a triple agonist like retatrutide) and might have greater side effects (the dose is larger since it goes through your digestive system) and you have to take it daily. But in any case, that will further box out semaglutide. Of course Novo has its own drug pipeline, but not clear if any of them are better than (or even equal to) retatrutide.
• haebom 1y ago
  When will Retatrutide release to the market?
  • phonon 1y ago
    Assuming the phase 3 trials are successful, probably late '26 or early '27.
    • haebom 1y ago
      Before that, I'll have to sell all my NN shares.